Filter posts

BIO Urges USTR To Take Action on Growing IP Barriers in Overseas Markets

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  In particular, …

Making Innovative Drugs Available Globally

In order to bring innovative biopharmaceutical to the global market companies must navigate the unique …

Head of Japan’s Drug Regulatory Authority Will Keynote BIO Asia

Since taking the role of chief executive of the Pharmaceuticals and Medical Devices Agency (PMDA) …

Happy 91st Birthday Senator Bayh!

At its best, government enables citizens to flourish socially and economically. Above and beyond the …

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an …

Interactive Map Displays Strength of Industry’s National Footprint

BIO’s biennial economic development and jobs report focuses on the economic progress and national footprint …

BIO Hosts Embassy Briefing on International Economic Development

Last week BIO hosted embassy representatives from over 25 countries to debut a new report …

USMCA Paves the Way for Biotech Innovation

After more than a year of high-stakes drama, the U.S. has inked an updated trade …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

Bipartisan SUCCESS Act is Good for American Innovation

Last week, the House Judiciary Committee unanimously reported the bipartisan SUCCESS Act. Co-sponsored by Representatives …